Document is current

Article History

Received: 5 December 2025

Accepted: 20 January 2026

First Online: 8 February 2026

Declarations

:

: None of the authors have competing interests.

: This information is provided under the section for Methods.

: Do not apply.

: The REBECCA consortium consists of 12 partners from 7 countries (Greece, Sweden, Norway, Spain, Luxembourg, Cyprus and Belgium). The consortium includes i.) Three universities with expertise in data analysis, machine learning and signal processing (Aristotle University of Thessaloniki (AUTH), The Centre for research and technology (CERTH), Harokopio University (HUA)), ii.) Four clinical centres with significant expertise in breast cancer research (SUH, Karolinska Institutet (KI), Region Stockholm (RSTO), INCLIVA Instituto de Investigación Sanitaria (INCLIVA), iii.) an expert in behaviour and lifestyle modelling (KI), iv.) an industry partner who actively develops large-scale solutions for the health care system (Netcompany- Intrasoft (INTRA)), v.) a partner that offers business modelling, analysis and ICT security services (8BELLS), vi.) a partner with legal and data security expertise (Timelex Law Firm), as well as vii.) a partner with expertise in data modelling, analytics services and data representation (European Health Management Association (EHMA)). In addition, the Swedish breast cancer association, Amazona, is involved in the project as user representatives. The project is coordinated by Professor Anastasios Delopoulos from the University of Aristotle in Thessaloniki (AUTH), Greece.